BioLineRx Ltd.（BLRX）重大事項與業績發布
| 申報日 | 表別 | 事項 | 原文 |
|---|---|---|---|
| 2026-08-28 | 6-K | — | SEC |
| 2026-08-18 | 6-K | — | SEC |
| 2026-07-08 | 6-K | — | SEC |
| 2026-05-27 | 6-K | — | SEC |
| 2026-05-22 | 6-K | — | SEC |
| 2026-05-19 | 6-K | — | SEC |
| 2026-04-28 | 6-K | — | SEC |
| 2026-03-26 | 6-K | — | SEC |
| 2026-03-23 | 6-K | — | SEC |
| 2026-02-23 | 6-K | — | SEC |
| 2025-11-24 | 6-K | — | SEC |
| 2025-11-17 | 6-K | — | SEC |
| 2025-09-29 | 6-K | — | SEC |
| 2025-08-14 | 6-K | — | SEC |
| 2025-06-30 | 6-K | — | SEC |
| 2025-05-30 | 6-K | — | SEC |
| 2025-05-27 | 6-K | — | SEC |
| 2025-05-23 | 6-K | — | SEC |
| 2025-03-31 | 6-K | — | SEC |
| 2025-01-21 | 6-K | — | SEC |
| 2025-01-17 | 6-K | — | SEC |
| 2025-01-07 | 6-K | — | SEC |
| 2025-01-06 | 6-K | — | SEC |
| 2024-11-25 | 6-K | — | SEC |
| 2024-11-21 | 6-K | — | SEC |
| 2024-11-12 | 6-K | — | SEC |
| 2024-11-05 | 6-K | — | SEC |
| 2024-10-16 | 6-K | — | SEC |
| 2024-10-01 | 6-K | — | SEC |
| 2024-08-19 | 6-K | — | SEC |
| 2024-08-15 | 6-K | — | SEC |
| 2024-06-18 | 6-K | — | SEC |
| 2024-05-30 | 6-K | — | SEC |
| 2024-05-28 | 6-K | — | SEC |
| 2024-05-24 | 6-K | — | SEC |
| 2024-05-17 | 6-K | — | SEC |
| 2024-05-06 | 6-K | — | SEC |
| 2024-04-17 | 6-K | — | SEC |
| 2024-04-10 | 6-K | — | SEC |
| 2024-04-01 | 6-K | — | SEC |
| 2024-03-26 | 6-K | — | SEC |
| 2024-03-04 | 6-K | — | SEC |
| 2024-02-28 | 6-K | — | SEC |
| 2024-02-16 | 6-K | — | SEC |
資料來自 SEC EDGAR 的 8-K／6-K 申報。8-K 是美國國內發行人的重大事項揭露（Item 2.02 為業績發布）；6-K 是外國發行人（含 ADR）的對應形式。本站僅整理連結，原文一律在 SEC 網站。